New JerseyState Snapshot for Chronic Kidney Disease

In this comparison, the NHQDR measures for New Jersey for the most recent data year and the baseline year are compared to the average of all States.

Due to changes in methodology, including a transition from International Classification of Diseases, Ninth Revision (ICD-9) to Tenth Revision (ICD-10) codes and updates to the Quality Indicators software, the current measure set does not contain AHRQ Quality Indicator measure results based on Healthcare Cost and Utilization Project (HCUP) data. These changes to the measure set had a significant impact on overall meter scores, so they are not provided at this time. When data become available, State scores will again be included.

Measures Better Than Average in The Recent Year
Measure Recent Year Recent Rate Recent Performance Baseline Year Baseline Rate Baseline Performance
Adult hemodialysis patients with adequate dialysis - (Kt/V) 1.2 or higher 2018 97.7 Better than Average 2015 95.2 Better than Average
Ratio of observed deaths to expected deaths among hemodialysis patients 2018 0.9 Better than Average 2000 1.1 Worse than Average
Hemodialysis patients whose hemoglobin level is less than 10 g/dL 2018 20.4 Better than Average 2015 21.2 Worse than Average
Dialysis patients who were registered on a waiting list for transplantation 2017 18.3 Better than Average 2000 19.3 Better than Average
Patients with treated chronic kidney failure who received a transplant within 3 years of date of renal failure 2014 14.6 Better than Average 2000 16.8 Worse than Average
Measures That Are Average in The Recent Year
Measure Recent Year Recent Rate Recent Performance Baseline Year Baseline Rate Baseline Performance
Adult hemodialysis patients who use arteriovenous fistulas as the primary mode of vascular access 2017 66.3 Average 2012 64.4 Better than Average
Measures Worse Than Average in The Recent Year
Measure Recent Year Recent Rate Recent Performance Baseline Year Baseline Rate Baseline Performance
Adult end stage renal disease (ESRD) patients who saw a nephrologist at least 12 months prior to initiation of renal replacement therapy 2017 33.0 Worse than Average 2012 31.8 Average